Compared with the moderate COVID-19 group, patients with mild COVID-19 were younger, had a shorter dialysis vintage, a lower prevalence of DM, CAD, or TB, lower IL-6 and PCT levels, and higher post-infection albumin level (p < .05). This evidence concerns the gene ALB and tuberculosis.